Charles Schwab Investment Management Inc. Grows Position in LifeStance Health Group, Inc. (NASDAQ:LFST)

Charles Schwab Investment Management Inc. grew its stake in shares of LifeStance Health Group, Inc. (NASDAQ:LFST) by 0.8% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 1,113,499 shares of the company’s stock after acquiring an additional 9,046 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in LifeStance Health Group were worth $8,206,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in LFST. Intech Investment Management LLC purchased a new stake in shares of LifeStance Health Group in the third quarter valued at $311,000. The Manufacturers Life Insurance Company boosted its holdings in LifeStance Health Group by 10.5% in the third quarter. The Manufacturers Life Insurance Company now owns 81,741 shares of the company’s stock valued at $572,000 after acquiring an additional 7,798 shares during the last quarter. Townsquare Capital LLC acquired a new position in LifeStance Health Group in the third quarter valued at $73,000. MetLife Investment Management LLC boosted its holdings in LifeStance Health Group by 14.3% in the third quarter. MetLife Investment Management LLC now owns 80,422 shares of the company’s stock valued at $563,000 after acquiring an additional 10,084 shares during the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in LifeStance Health Group by 31.4% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 24,105 shares of the company’s stock valued at $169,000 after acquiring an additional 5,767 shares during the last quarter. Hedge funds and other institutional investors own 85.50% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on LFST. The Goldman Sachs Group upgraded LifeStance Health Group from a “neutral” rating to a “buy” rating and set a $10.00 target price on the stock in a report on Monday, December 16th. William Blair reiterated an “outperform” rating on shares of LifeStance Health Group in a report on Friday, February 28th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $8.63.

Insider Activity at LifeStance Health Group

In other news, insider Lisa K. Miller sold 18,845 shares of the company’s stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $6.90, for a total transaction of $130,030.50. Following the completion of the transaction, the insider now directly owns 339,810 shares of the company’s stock, valued at approximately $2,344,689. This represents a 5.25 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 6.60% of the stock is owned by corporate insiders.

LifeStance Health Group Stock Up 0.4 %

Shares of LifeStance Health Group stock opened at $6.85 on Monday. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.19. The firm has a market cap of $2.63 billion, a P/E ratio of -26.35 and a beta of 1.27. LifeStance Health Group, Inc. has a fifty-two week low of $4.64 and a fifty-two week high of $8.61. The business has a 50-day moving average price of $7.72 and a 200 day moving average price of $7.36.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.